Top Abstract Purchase Related
Home
>
Node
>
Subnode

Role of thromboxanes in hepatic ischemia

Balladur, P.; Besse, T.; Lambotte, L.

Chirurgie; Memoires de l'Academie de Chirurgie 116(8-9): 704-710

1990

ISSN/ISBN: 0001-4001
PMID: 2129988
Document Number: 350362
Thromboxanes and prostacyclins are two prostanoids that may play an important part in the hepatic lesions induced by ischemia. In order to study this hypothesis, we have compared the survival rate of rats submitted to a 90-minute warm ischemia by giving them agents inhibiting the synthesis of thromboxanes and/or exogenic PGI2. Simultaneously, we have measured the rate of production of TxA2 and PGI2 by the hepatic tissue after 90-minute ischemia and after 30-minute reperfusion. Our results suggest that the decrease in the thromboxane level is a deciding factor of improvement in the tolerance of the liver to ischemia. The drug that allows achieving the best survival rate and the greatest decrease in the thromboxane levels is Imidazole.

Document emailed within 1 workday
Secure & encrypted payments

Boĭko, V.V.; Pisetskaia, M.É; Tishchenko, A.M.; Skoryĭ, D.I.; Kozlova, T.V.; Gorgol', N.I.; Volchenko, I.V. 2013: The role of ischemical preconditioning in the development of ischemia-reperfusion hepatic injury in experiment Klinichna Khirurhiia 5: 72-76
Khodosovskiĭ, M.N.; Zinchuk, V.V. 2014: The role of NO-dependent mechanisms in melatonin antioxidant activity during hepatic ischemia-reperfusion in rats Eksperimental'naia i Klinicheskaia Farmakologiia 77(6): 33-38
Kelly, J.P.; Johnson, M.C.; Parker, C.W. 1979: Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway Journal of Immunology 122(4): 1563-1571
Izu, M. 1992: Investigation of hepatic energy metabolism in normothermic hepatic ischemia--comparison between normal and cirrhotic rat liver Nihon Geka Gakkai Zasshi 93(1): 52-61
Kurihara, M.; Miyazaki, M.; Shimura, T.; Takahashi, O.; Okui, K. 1989: Beneficial effects of glucagon-insulin infusion on hepatic protein synthesis and DNA synthesis in partial hepatic ischemia Nihon Geka Gakkai Zasshi 90(7): 1019-1025
Gayraud, M.; Thaler, F.; Roullet-Audy, J.C.; Rebibo, G. 1987: Localized hepatic ischemia Annales de Medecine Interne 138(3): 220
Jensen, R.; Johnson, L.W.; Lauerman, L.H.; Tucker, J.O.; Swift, B.L.; Alexander, A.F.; Hancock, H.A.; Flack, D.E.; Braddy, P.M.; Horton, D.P. 1982: Ischemia: a cause of hepatic telangiectasis in cattle American Journal of Veterinary Research 43(8): 1436-1439
Chu, C.J.; Chen, C.T.; Wang, S.S.; Lee, F.Y.; Chang, F.Y.; Lin, H.C.; Wu, S.L.; Lu, R.H.; Chan, C.C.; Huang, H.C.; Lee, S.D. 2001: Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha Zhonghua Yi Xue Za Zhi 64(6): 321-330
Sokirchenko, I.A.; Shkurupiĭ, V.A. 1985: Changes in the ultrastructure of rat hepatocytes at different periods after hepatic ischemia Biulleten' Eksperimental'noi Biologii i Meditsiny 100(9): 358-360
Huguet, C.; Gavelli, A.; Chieco, P.A.; Bona, S.; Harb, J.; Joseph, J.M.; Jobard, J.; Gramaglia, M.; Lasserre, M. 1992: Liver ischemia for hepatic resection: where is the limit? Surgery 111(3): 251-259
Gonçalez, Y.; Machado, M.C.; Gonçalves, E.L. 1979: Hepatic ischemia and glycogen: an experimental study Revista do Hospital das Clinicas 34(2): 74-79
Luo, Y.-H.; Li, Z.-D.; Liu, L.-X.; Dong, G.-H. 2009: Pretreatment with erythropoietin reduces hepatic ischemia-reperfusion injury Hepatobiliary and Pancreatic Diseases International: Hbpd Int 8(3): 294-299
Kobayashi, T.; Sakurai, H. 1985: Progress in the technology of prostaglandin isolation and analysis (prostaglandins, thromboxanes, and leukotrienes) Nihon Rinsho. Japanese Journal of Clinical Medicine 43(3): 608-614
Murota, S. 1982: Recent progress in prostaglandin research. Biochemistry of thromboxanes, prostacyclin, and leukotrienes Seikagaku. Journal of Japanese Biochemical Society 54(1): 1-23
Wu, H.-S.; Zhang, J.-X.; Wang, L.; Tian, Y.; Wang, H.; Rotstein, O. 2004: Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice Hepatobiliary and Pancreatic Diseases International: Hbpd Int 3(2): 250-253
Chien-Hua, L.; Jyh-Cherng, Y.; Huan-Fa, H.; Hurng-Sheng, W.; Shih-Yi, C.; Chu-Hsin, C. 2007: Pneumatosis intestinalis and hepatic-portal-mesenteric venous gas in intestinal ischemia Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 99(2): 96-99
Ye, H.; Fu, X.-g.; Lu, H.; Mao, D. 2010: Protective effect of Salvia on ischemia-reperfusion hepatic injury in rats Zhonghua Yi Xue Za Zhi 90(26): 1854-1858
Shiraki, K.; Neustein, H.B. 1971: Intramitochondrial crystalloids and amorphous granules. Occurrence in experimental hepatic ischemia in dogs Archives of Pathology 91(1): 32-40
Wang, L.; Xu, J.-B.; Wu, H.-S.; Zhang, J.-X.; Zhang, J.-H.; Tian, Y.; Wang, C.-Y. 2006: The relationship between activation of TLR4 and partial hepatic ischemia/reperfusion injury in mice Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(1): 101-104
Elimadi, A.; Settaf, A.; Morin, D.; Sapena, R.; Lamchouri, F.; Cherrah, Y.; Tillement, J.P. 1998: Trimetazidine counteracts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial function Journal of Pharmacology and Experimental Therapeutics 286(1): 23-28